Virtus ETF Advisers LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 118 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$99,000
-32.2%
20,379
-5.0%
0.04%
-26.7%
Q2 2021$146,000
-64.6%
21,447
-49.6%
0.06%
+39.5%
Q3 2018$413,000
-45.1%
42,584
-42.3%
0.04%
-93.5%
Q2 2018$752,000
+35.3%
73,770
+72.6%
0.66%
+38.0%
Q1 2018$556,000
+58.9%
42,733
+118.2%
0.48%
+9.8%
Q4 2017$350,000
-5.4%
19,580
+33.0%
0.44%
+778.0%
Q3 2017$370,000
+14.9%
14,726
+10.1%
0.05%
+4.2%
Q2 2017$322,000
-17.2%
13,379
-33.8%
0.05%
-30.4%
Q1 2017$389,000
+38.4%
20,209
+10.6%
0.07%
-17.9%
Q4 2016$281,000
+24.3%
18,271
+22.8%
0.08%
-73.0%
Q1 2016$226,000
-24.7%
14,884
-5.9%
0.31%
-62.2%
Q4 2015$300,00015,8190.82%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders